About Srikar Biotech Private Limited
Data last updated: 31 December 2025
Srikar Biotech Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in crop protection, a part of the broader agriculture sector. Incorporated on 26 May 2008, the company has been in operation for over 18 years.
Registered with ROC Hyderabad under CIN U85100AP2008PTC059337.
Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹39.75 Cr. It is led by directors including Usha Rani Papineni and Sanjeev Jakkanisanjeev.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Shed – 1 Plot No.A11 & A12/1 Ida Nacharam Medchal, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2025, the company reported a revenue of ₹180.4 Cr, a growth of 22% compared to the previous year.
The company has a workforce of approximately 61 employees as per the latest available data.
The company is associated with 2 brands - Srikar Group, Srikar Biotech. As per MCA filings, the company has open charges of ₹412.84 Cr and satisfied charges of ₹52.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website srikarbiotech.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressShed – 1 Plot No.A11 & A12/1 Ida Nacharam Medchal, Hyderabad, Telangana, India – 500076
-
IndustryAgriculture, Crop Protection, Fertilizers & Soil Enhancers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Srikar Biotech Private Limited
Srikar Biotech Private Limited has one previous CIN (Corporate Identification Number): U85100AP2008PTC059337. The current CIN is U85100TG2008PTC059337, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100TG2008PTC059337 | Current |
| U85100AP2008PTC059337 | Previous |
Associated Brands with Srikar Biotech Private Limited
Srikar Biotech Private Limited operates two associated brands: Srikar Group and Srikar Biotech. These brands represent Srikar Biotech Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| It serves as a srikar group. | srikargroup.com | |
| Agriculture products, fertilizers, and pesticides in Hyderabad. | srikarbiotech.com |
Business Activity of Srikar Biotech Private Limited
Srikar Biotech Private Limited is engaged in the principal business activity of agriculture, forestry, fishing, with detailed activities including support activities to agriculture and other activities including hunting.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A4 | Support activities to agriculture and Other Activities including hunting | ********* |
Board of Directors of Srikar Biotech Private Limited
Srikar Biotech Private Limited is currently managed by 5 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Usha Rani Papineni
Also directs:
Srikar Seeds Private Limited, Srikar Dairy Private Limited, Eldorado Agritech Limited and 4 more
|
Managing Director | 26 May 2008 | 18 Years 1 Months | Current |
|
Sanjeev Jakkanisanjeev
Also directs:
Eldorado Agritech Limited
|
Cfo | 09 Apr 2025 | 1 Years 3 Months | Current |
| Karunasree Samudrala | Director | 21 Jul 2025 | 0 Years 11 Months | Current |
|
Srinivasa Rao Linga
Also directs:
Srikar Seeds Private Limited, Srikar Dairy Private Limited, Eldorado Agritech Limited and 4 more
|
Director | 26 May 2008 | 18 Years 1 Months | Current |
Financials of Srikar Biotech Private Limited FY 2025 filings available
Srikar Biotech Private Limited reported revenue of ₹180.4 Cr (up 22% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Srikar Biotech Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2025 | The Hongkong and Shanghai Banking Corporation Limited | ₹57.35 Cr | Open |
| 20 Jun 2025 | Hdfc Bank Limited | ₹86.49 Cr | Open |
| 20 Jun 2025 | Hdfc Bank Limited | ₹73.7 Cr | Open |
| 05 Mar 2025 | Hdfc Bank Limited | ₹53.28 Cr | Open |
| 27 Sep 2024 | Others | ₹60 Cr | Open |
Total charge records: 50 View all charges
Employees and EPFO Compliance at Srikar Biotech Private Limited
View historical data on people associated with Srikar Biotech Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Srikar Biotech Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Srikar Biotech Private Limited
GSTIN & GST Filing Data of Srikar Biotech Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Srikar Biotech Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Srikar Biotech Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Srikar Biotech Private Limited
MSME Payment Delays by Srikar Biotech Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Srikar Biotech Private Limited
Subsidiaries & Group Companies of Srikar Biotech Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Srikar Biotech Private Limited with ownership details.
MCA Filings & Documents of Srikar Biotech Private Limited
MCA Filings & Documents of Srikar Biotech Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Srikar Biotech Private Limited
Frequently Asked Questions about Srikar Biotech Private Limited
Srikar Biotech Private Limited is an active private limited company in the agriculture sector based in Hyderabad, Telangana, India. It was incorporated on 26 May 2008 (18+ years old) and is registered under CIN U85100TG2008PTC059337. The company has 61 employees.
Srikar Biotech Private Limited reported revenue of ₹180.4 Cr for FY 2025 (up 22.00% YoY).
The current directors of Srikar Biotech Private Limited are:
- Usha Rani Papineni
- Sanjeev Jakkanisanjeev
- Karunasree Samudrala
- Srinivasa Rao Linga
- Sanjeev Jakkanisanjeev
The primary industry of Srikar Biotech Private Limited is agriculture. The company specifically operates in crop protection. The company is currently active in this sector.
Srikar Biotech Private Limited can be reached at the registered office: Shed – 1 Plot No.A11 & A121 Ida Nacharam Medchal, Hyderabad, Telangana, India – 500076, or through the website srikarbiotech.com.
The authorised capital is ₹50 Cr, and the paid-up capital is ₹39.75 Cr.